Are diuretics contraindicated in patients with acute-on-chronic liver failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diuretics Are NOT Contraindicated in ACLF

Diuretics are not contraindicated in patients with acute-on-chronic liver failure (ACLF), but they require careful monitoring and should be reduced or discontinued if complications develop, particularly acute kidney injury, severe hyponatremia, or hepatic encephalopathy. 1

Evidence-Based Approach

The 2021 BSG/British Association for the Study of the Liver guidelines explicitly address diuretic use in cirrhosis with ascites, including patients with ACLF. The guidelines recommend standard diuretic therapy with spironolactone (starting 100 mg, up to 400 mg daily) combined with furosemide (starting 40 mg, up to 160 mg daily) for patients with ascites 1. Importantly, there is no specific contraindication listed for ACLF patients.

When to Use Caution

While not contraindicated, diuretics should be reduced or stopped in the following situations 2:

  • Severe hyponatremia (sodium <125 mmol/L)
  • Acute kidney injury (AKI)
  • Overt hepatic encephalopathy
  • Severe muscle spasms
  • Hypotension or progressive renal dysfunction

The Korean Association for the Study of the Liver (KASL) 2018 guidelines similarly state that diuretics should be reduced or stopped in cases of severe hyponatremia, AKI, overt hepatic encephalopathy, or severe muscle spasm 2.

Clinical Context for ACLF

ACLF patients are at higher risk for complications, which is why the guidelines specifically mention them in the context of albumin administration after paracentesis. The 2021 BSG guidelines note that albumin can be considered after paracentesis of <5 L "in patients with ACLF or high risk of post-paracentesis acute kidney injury" 1. This acknowledges that ACLF patients are more vulnerable but does not prohibit diuretic use.

Monitoring Requirements

All patients on diuretics require close monitoring 1:

  • Body weight daily
  • Vital signs
  • Serum creatinine
  • Serum sodium and potassium
  • Clinical assessment for volume status

In ACLF patients, this monitoring becomes even more critical given their propensity for rapid deterioration and multiorgan failure 3.

Alternative Management

If diuretics are poorly tolerated or ineffective, large-volume paracentesis (LVP) with albumin replacement becomes the primary management strategy 1, 2. For ACLF patients specifically, albumin at 8 g/L of ascites removed should be considered even for paracentesis <5 L 1.

Common Pitfall

The main pitfall is continuing diuretics in the face of developing complications. The evidence shows that almost half of patients on diuretics develop adverse events requiring dose reduction or discontinuation 1. In ACLF, where organ failures can progress rapidly, failing to recognize and respond to diuretic-induced complications (particularly AKI) can worsen outcomes and mortality.

Bottom line: Use diuretics in ACLF with standard dosing, but maintain heightened vigilance for complications and have a low threshold to reduce or stop them if renal function deteriorates, severe hyponatremia develops, or encephalopathy worsens.

Related Questions

In a patient with acute‑on‑chronic liver failure from alcoholic hepatitis who has no burr cells on peripheral smear and a low lipid profile, what is the most likely cause of the hemolysis and how should it be managed?
What are the indications for diuretic use in chronic liver disease?
In patients with acute‑on‑chronic liver failure, how should ascitic fluid adenosine deaminase levels be interpreted and used in the diagnostic work‑up?
What are the causes of hemolysis in acute and chronic liver failure?
Can you provide a comprehensive comparison of acute liver failure versus chronic liver failure for a presentation?
In a 77-year-old patient with bleeding hemorrhoids, should apixaban (Eliquis) be stopped, and should I bridge with low-molecular-weight heparin or continue without bridging?
What are the typical clinical signs of a cerebellar stroke?
Can a thoracic paravertebral block be used for analgesia in an adult undergoing open cholecystectomy with skin wound exploration, assuming no contraindications?
What is the technique for performing a landmark-guided thoracic paravertebral block in an adult patient undergoing an open cholecystectomy?
Can you interpret the MRI findings of an L5‑S1 disc abnormality (dissection) with preserved lumbar lordosis, no Modic end‑plate changes, normal vertebral body height and marrow signal, normal conus medullaris and cauda equina, and no paravertebral mass?
What is the appropriate treatment for a 16‑week pregnant woman with cholecystolithiasis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.